Evidence for reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas
1996

bcl-2 and p53 Expression in Colorectal Cancer

Sample size: 72 publication Evidence: moderate

Author Information

Author(s): AJM Watson, AJ Merritt, LS Jones, JN Askew, E Anderson, A Becciolini, M Balzi, CS Potten, JA Hickman

Primary Institution: University of Manchester

Hypothesis

Is the expression of bcl-2 and p53 inversely related in colorectal adenomas and carcinomas?

Conclusion

The study found that bcl-2 is expressed in a higher proportion of adenomas than carcinomas, and there is an inverse relationship between bcl-2 and p53 expression.

Supporting Evidence

  • 63.2% of adenomas expressed bcl-2 compared to 36.5% of carcinomas.
  • 31.6% of adenomas expressed p53 compared to 62.3% of carcinomas.
  • Only 1 out of 19 adenomas and 2 out of 53 carcinomas expressed both bcl-2 and p53.

Takeaway

This study looked at how two proteins, bcl-2 and p53, behave in colon tumors. It found that bcl-2 helps some tumors grow, but as they become more serious, they often lose bcl-2 and gain p53.

Methodology

Immunohistochemistry was used to determine the expression of bcl-2 and p53 in colorectal adenomas and carcinomas.

Limitations

The study's sample size may limit the generalizability of the findings.

Statistical Information

P-Value

p<0.05 for bcl-2 expression in adenomas vs. carcinomas; p<0.02 for p53 expression in adenomas vs. carcinomas.

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication